Earnings summaries and quarterly performance for 908 Devices.
Executive leadership at 908 Devices.
Board of directors at 908 Devices.
Research analysts who have asked questions during 908 Devices earnings calls.
Puneet Souda
Leerink Partners
4 questions for MASS
Also covers: A, ABCL, BRKR +20 more
Daniel Arias
Stifel, Nicolaus & Company, Incorporated
3 questions for MASS
Also covers: A, AVTR, CDXS +15 more
Chad Wiatrowski
TD Cowen
2 questions for MASS
Also covers: BLFS, CDXS, CTKB +4 more
Jacob Krahenbuhl
William Blair
2 questions for MASS
Also covers: TXG
Brendan Smith
Stifel, Nicolaus & Company, Incorporated
1 question for MASS
Also covers: ABCL, ABSI, ARWR +19 more
Chad Wyrowski
TD Cowen
1 question for MASS
Hannah Hefley
Stephens
1 question for MASS
Also covers: AZTA, MXCT, TECH
Matthew Larew
William Blair & Company
1 question for MASS
Also covers: AMED, ATR, DNA +10 more
Sam Martin
William Blair
1 question for MASS
Recent press releases and 8-K filings for MASS.
908 Devices Discusses Strategic Transformation and Growth Outlook
MASS
Guidance Update
Product Launch
Revenue Acceleration/Inflection
- 908 Devices (MASS) has completed a "908 2.0" transformation, pivoting to focus on purpose-built, handheld chemical detection for public health, safety, and defense markets after divesting its desktop business. This strategic shift aims for a sharper focus, stronger financial position, and clearer operational alignment.
- The company reported 16% revenue growth year-to-date through the first nine months of 2025, with Q3 gross margins at 58% and year-to-date gross margins at 56%. Adjusted EBITDA loss improved 32% year-over-year and 53% quarter-over-quarter in Q3, and 908 Devices is on track to achieve adjusted EBITDA profitability in Q4 2025.
- Full-year 2025 revenue guidance was reiterated at $54 million-$56 million. For 2026, the company projects product growth of 20% plus, driven by legacy product upgrades, new product innovation (Explorer, Viper), and the DOD AFCAD program. The company ended Q3 with a strong cash position of $112 million and no debt.
Nov 20, 2025, 4:00 PM
908 Devices Discusses Strategic Pivot, Growth Projections, and Path to Profitability
MASS
Guidance Update
Product Launch
Revenue Acceleration/Inflection
- 908 Devices (MASS) has completed a "908 2.0" transformation, pivoting to focus on purpose-built, handheld chemical detection for public health, safety, and defense after divesting its desktop business.
- The company projects 13%-17% growth for 2025 and anticipates accelerating to 20%+ product growth in 2026.
- 908 Devices is on track to achieve adjusted EBITDA profitability in Q4 2025, with Q3 2025 adjusted EBITDA loss improving 32% year over year and 53% quarter over quarter to $1.8 million.
- Year-to-date through Q3 2025, the company reported 16% revenue growth and 56% gross margins, with Q3 gross margins at 58%. Full-year 2025 revenue guidance was reiterated at $54 million-$56 million.
- Key growth catalysts for 2026 include equipment modernization, continued innovation with new product launches like Viper and Explorer, and the DOD AFCAD program, which has a potential of $10 million+ when fully ramped.
Nov 20, 2025, 4:00 PM
908 Devices Details Strategic Pivot and Growth Outlook at Stephens Conference
MASS
Guidance Update
Product Launch
Revenue Acceleration/Inflection
- 908 Devices (MASS) has completed a transformational pivot (908 2.0), divesting its desktop business to focus entirely on handheld chemical detection for public health, safety, and defense markets.
- The company reported 16% year-to-date revenue growth and 56% year-to-date gross margins (58% in Q3 2025), with an adjusted EBITDA loss of $1.8 million in Q3 2025.
- Management reiterated its full-year 2025 revenue guidance of $54 million-$56 million and expects to achieve positive adjusted EBITDA in Q4 2025.
- New product launches, including Viper (launched in July 2025) and Explorer, are driving growth, with Explorer growing 30% quarter-over-quarter in Q3 2025.
- The company projects 13%-17% growth for 2025, accelerating to 20% plus product growth in 2026, supported by a strong cash position of $112 million and no debt as of Q3 2025.
Nov 20, 2025, 4:00 PM
908 Devices Reports Q3 2025 Revenue Beat, Strategic Transformation, and Q4 Positive EBITDA Outlook
MASS
Guidance Update
Product Launch
M&A
- 908 Devices reported Q3 2025 revenue of $14 million, surpassing the $13.5 million consensus, and maintained its full-year guidance.
- The company completed a transformation by divesting its PAT business for $70 million in proceeds, resulting in $112 million cash at the end of Q3, and acquired RedWave, which expanded its handheld product portfolio to five offerings.
- Management expects to achieve adjusted positive EBITDA in Q4 2025 and projects 20% product growth in 2026.
- Key growth drivers include the recently launched Viper product, with 35 units in hand for Q4 representing approximately 15% of the Q4 revenue midpoint guidance, and the Avcad program, which could generate $10 million+ annually starting in 2026.
- The company faces potential headwinds from a $4 million impact on Q4 revenue due to government shutdown-related delays and a $2 million headwind for 2026 from a large military program customer.
Nov 12, 2025, 1:40 PM
908 Devices Reports Q3 2025 Financial Results, Maintains Full-Year Guidance
MASS
Earnings
Guidance Update
Product Launch
- 908 Devices reported Q3 2025 revenue from continuing operations of $14 million, a 4% decrease year-over-year but an 8% sequential increase, contributing to $38.8 million in year-to-date revenue, up 16% year-over-year.
- The company achieved its lowest adjusted EBITDA loss in public company history at $1.8 million for Q3 2025, a 53% quarter-over-quarter reduction, and is on track to achieve adjusted EBITDA positivity in Q4 2025.
- Full-year 2025 revenue guidance for continuing operations remains $54-$56 million, despite an estimated $4 million of Q4 revenue potentially impacted by U.S. government shutdown delays, which are viewed as a timing issue.
- Key product highlights include strong demand for the Explorer Gas Identification device, which accounted for 42% of Q3 revenue, and the newly launched VIPER handheld chemical analyzer, which has secured over 35 units for Q4 shipment.
- 908 Devices concluded Q3 2025 with a strong balance sheet, holding $112.1 million in cash, cash equivalents, and marketable securities and no debt.
Nov 10, 2025, 1:30 PM
908 Devices Reports Q3 2025 Financial Results and Reaffirms 2025 Revenue Outlook
MASS
Earnings
Guidance Update
Demand Weakening
- 908 Devices Inc. reported $14.0 million in revenue for the third quarter of 2025, a 4% decrease year over year, while year-to-date revenue for the first nine months of 2025 increased 16% to $38.8 million.
- The company achieved an Adjusted EBITDA loss of $1.8 million for Q3 2025, representing a 53% improvement quarter over quarter, and ended the quarter with $112 million in cash, cash equivalents, and marketable securities.
- 908 Devices reiterated its full year 2025 revenue guidance, expecting revenues from continuing operations to be in the range of $54.0 million to $56.0 million, which would represent 13% to 17% growth compared to 2024.
Nov 10, 2025, 12:15 PM
Quarterly earnings call transcripts for 908 Devices.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more